	Proton Therapy for Breast, Prostate, and Leptomeningeal Disease-Some Answers, but Questions Persist. Int J Radiat Oncol Biol Phys Narra LR, Dess RT, Anderson B, Kim MM, Jabbour SK. PMID: 42874645 [PubMed - in process]
	Effect of electromagnetic waves from doxorubicin on breast cancer growth in a mouse model. Cancer Treat Res Commun Al-Ghamdi FH, Abou Al-Saud S, AlShammari HF, Binobaid L, Almousa R. PMID: 42874442 [PubMed - as supplied by publisher]
	Survival and disease burden of breast cancer (Monastir, Tunisia): A population-based cohort study (2002-2022). PLoS One Zemni I, Maatouk A, Boufrikha W, Bennasrallah C, Dhouib W, Kacem M, Abroug H, Ben Fredj M, Bouanene I, Jridi I, Arfa H, Ben Salem A, Njim L, Zaied S, Faleh R, Sakka K, Sriha B, Jaîdane L, Mehdi M, Belguith Sriha A. PMID: 42873796 [PubMed - indexed for MEDLINE]
	A randomized phase II study of fulvestrant with or without ganetespib in patients with endocrine resistant metastatic breast cancer. Oncologist Grinshpun A, Waks AG, Fu J, Kurnia P, Guo H, Li T, Moore M, DiLullo M, Patel A, Whitesell L, Atanasov S, Partridge AH, Mayer EL, Krop IE, Santagata S, Brown M, Winer EP, Reeder-Hayes K, Anders C, Jeselsohn R, Lin NU. PMID: 42873573 [PubMed - as supplied by publisher]
	Beyond demographics: physical activity as a key behavioral marker for identifying the guidance-seeking profile to guide precision survivorship care. Support Care Cancer Yao Y, Xiao R, Cheng Q, Lei X, Wu H, Liu X. PMID: 42873292 [PubMed - indexed for MEDLINE]
	Neutrophil Extracellular Traps as Predictive Biomarkers in Trastuzumab-Treated HER2-Positive Breast Cancer: A Prospective Cohort Study. J Vis Exp Wang Y, Wang L, Zhao L, Zhou L, Chen H, Zhang Y, Liu S, Zhu T. PMID: 42872727 [PubMed - indexed for MEDLINE]
	TroFuse-032 study design: pembrolizumab plus sacituzumab tirumotecan or chemotherapy followed by pembrolizumab plus chemotherapy as neoadjuvant therapy for early-stage, triple-negative breast cancer or HR-low+/HER2- breast cancer. Future Oncol Schmid P, Cortes J, Hui R, Masuda N, Garrido-Castro AC, Loirat D, Shao ZM, Park YH, Wei J, Beca F, Malhotra U, Harbeck N. PMID: 42872715 [PubMed - as supplied by publisher]
	Financial Toxicity and Follow-Up Quality of Life Among Breast Cancer Survivors in the BOLD Cohort. Psychooncology Wu IHC, Vogel RI, Jewett PI, Blaes AH. PMID: 42872673 [PubMed - indexed for MEDLINE]
	Linitis plastica-like metastasis of invasive lobular carcinoma: a diagnostically challenging case report and literature review. Acta Gastroenterol Belg Ogur T, Schoneveld M, Verlinden L, De Mey J, Sahebali S, Brussaard C. PMID: 42872340 [PubMed - indexed for MEDLINE]
	Inflammatory Potential of Diet and Breast Cancer Risk: A Population-Based Case-Control Study. Food Sci Nutr Amani-Beni R, Price S, Darouei B, Abdollahpour I, Javanmard SH, Zendehdel K, Hebert JR. PMID: 42872120 [PubMed]
	Therapy-induced senescence in breast cancer and cardiovascular disease: a double-edged biological process. Front Cardiovasc Med Belcastro E, Fanelli GN, Schiavone ML, Di Cocco F, Cateni C, Naccarato AG, Scatena C, Schini-Kerth VB. PMID: 42871672 [PubMed]
	Advancing Breast Cancer Diagnosis with Deep Layer-wise Feature Integration from Histopathology Images. J Biomed Phys Eng Madani M, Shabani H. PMID: 42871547 [PubMed]
	AI-driven multi-omics biomarkers in precision breast cancer therapeutics: from discovery to clinical translation. Front Pharmacol Stylianakis D, Sánchez-Bayona R, Denaro N, Solinas C. PMID: 42871535 [PubMed]
	Diet, hormones, and breast cancer: biomarker-guided assessment of risk and prognosis. Front Immunol Liu J, Liu M, Zhong X, Sun Q, Zhou X. PMID: 42871510 [PubMed - indexed for MEDLINE]
	Metastatic HER2-positive breast cancer in a 19-year-old woman following a 4-year diagnostic delay: a case report. AME Case Rep Ling M, Tsavaris N, Jenkins A, Bhagat D, Jeffery K. PMID: 42871456 [PubMed]
	Automatic grading of HER2 immunohistochemical whole-slide images based on a multi-scale hierarchical graph neural network. Front Public Health Jiang Y, Sun W, Ye C, Xu C, Xue J, Wang Y, Yan S, Li Y, Bai C. PMID: 42870985 [PubMed - indexed for MEDLINE]
	Expression, prognostic association, and immune microenvironment correlates of C4orf50 in breast cancer: a The Cancer Genome Atlas Breast Invasive Carcinoma (TCGA-BRCA) bioinformatics study. Transl Cancer Res Lin S, Liu L, Guan J, Wang J, Cen C, Wei L, Yang H. PMID: 42870827 [PubMed]
	DNA-Based Biomarkers as Predictors of Carboplatin Response in Neoadjuvant Treatment for Hormone Receptor Positive and Triple-Negative Breast Cancer. Clin Cancer Res Pladsen AV, Smebye ML, Garred Ø, Borgen E, Egeland EV, Haugen MH, Dahle MA, Prasmickaite L, Mælandsmo GM, Hovig E, Nakken S, Østgaard A, Bergheim IR, Reinertsen K, Ohnstad HO, Schlichting E, Skjerven HK, Dale AB, Wist E, Naume B, Russnes HG, Lingjærde OC, Engebraaten O. PMID: 42870529 [PubMed - as supplied by publisher]
	Machine Learning-Guided Identification of Madecassoside as a Potential RAD51 Modulator That Sensitizes Breast Cancer Cells to Cisplatin. Chem Biol Drug Des Oh M, Jeong MY, Choi J. PMID: 42870317 [PubMed - indexed for MEDLINE]
	HCF-Net: a Hierarchical Cascade Fusion Network Aligned with Clinical Treatment Pathways for Preoperative Molecular Subtyping of Breast Cancer on Dynamic Contrast-Enhanced MRI. J Imaging Inform Med Chen Y, Hu L, Hou J, Xie Y, Nie S, Jiang Y, Han B, Li X. PMID: 42870154 [PubMed - as supplied by publisher]

Articles 1 - 20 / 223033

Page 1 of 11152



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy